8-K
Current Report
Kairos Pharma, LTD. Filed Acc 0001493152-26-034185
Material agreement · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading form8-k.htm…